By NewsDesk @infectiousdiseasenews
On Friday morning, the U.S. Food and Drug Administration amended the emergency use authorizations (EUA) for both the Moderna and Pfizer-BioNTech COVID-19 vaccines authorizing use of a single booster dose for all individuals 18 years of age and older after completion of primary vaccination with any FDA-authorized or approved COVID-19 vaccine.
“The FDA has determined that the currently available data support expanding the eligibility of a single booster dose of the Moderna and Pfizer-BioNTech COVID-19 vaccines to individuals 18 years of age and older,” said Peter Marks, M.D., Ph.D., director of the FDA’s Center for Biologics Evaluation and Research. “Streamlining the eligibility criteria and making booster doses available to all individuals 18 years of age and older will also help to eliminate confusion about who may receive a booster dose and ensure booster doses are available to all who may need one.”
The Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) met later that day.
By the late afternoon, CDC Director Rochelle P. Walensky, M.D., M.P.H., announced the endorsement of ACIP’s expanded recommendations for booster shots to include all adults ages 18 years and older who received a Pfizer-BioNTech or Moderna vaccine at least six months after their second dose.
The Food and Drug Administration’s (FDA) authorization and CDC’s recommendation for use are critical next steps forward in our country’s booster program – a program which will help provide increased protection against COVID-19 disease and death.
CDC continues to encourage the 47 million adults who are not yet vaccinated to get vaccinated as soon as possible to protect themselves, their families, loved ones and communities. We also strongly encourage those who were already eligible – older populations and individuals with underlying medical conditions – to get boosted before the holidays.
Anyone can find available vaccines near them at vaccines.gov and can consult their health care provider or local pharmacist if they have questions about vaccines or boosters.
Dr. Walensky said, “After critical scientific evaluation, today’s unanimous decision carefully considered the current state of the pandemic, the latest vaccine effectiveness data over time, and review of safety data from people who have already received a COVID-19 primary vaccine series and booster. Booster shots have demonstrated the ability to safely increase people’s protection against infection and severe outcomes and are an important public health tool to strengthen our defenses against the virus as we enter the winter holidays. Based on the compelling evidence, all adults over 18 should now have equitable access to a COVID-19 booster dose.”
- Spain: Legionellosis outbreak reported in Montmeló and Montornès del Vallès
- Austria goes into full lockdown: It was not a popular decision, ‘but a necessary one’; Upcoming vaccine mandate
- ‘Smallpox’ labeled vials actually contain vaccinia: CDC
- Argentina: Suspected case of cutaneous anthrax reported in La Pampa
- Fighting West Nile Virus by adding ivermectin to backyard bird feeders
- Ivermectin credited with eliminating river blindness in Plateau and Nasarawa states in Nigeria
- Europe Newswire: COVID-19 rising